Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Nagy

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Viruses|January 24, 2020
Multi-Approach Investigation Regarding the West Nile Virus Situation in Hungary, 2018Brigitta Zana, Károly Erdélyi, Anna Nagy, et al.
Journal of the American College of Cardiology|April 29, 2026
Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular ConditionsAnika Misra, Amanda Jowell, Sara Haidermota, et al.
American Journal of Human Genetics|September 17, 2024
The BabySeq Project: A clinical trial of genome sequencing in a diverse cohort of infantsHadley Stevens Smith, Bethany Zettler, Casie A Genetti, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Circulation|May 15, 2023
Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart DiseaseYiyi Zhang, Jacqueline S Dron, Brandon K Bellows, et al.
JAMA Cardiology|January 31, 2024
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated CholesterolYiyi Zhang, Jacqueline S Dron, Brandon K Bellows, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Cerebellum (London, England)|December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Viruses|January 24, 2020
Multi-Approach Investigation Regarding the West Nile Virus Situation in Hungary, 2018Brigitta Zana, Károly Erdélyi, Anna Nagy, et al.
Journal of the American College of Cardiology|April 29, 2026
Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular ConditionsAnika Misra, Amanda Jowell, Sara Haidermota, et al.
American Journal of Human Genetics|September 17, 2024
The BabySeq Project: A clinical trial of genome sequencing in a diverse cohort of infantsHadley Stevens Smith, Bethany Zettler, Casie A Genetti, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Circulation|May 15, 2023
Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart DiseaseYiyi Zhang, Jacqueline S Dron, Brandon K Bellows, et al.
JAMA Cardiology|January 31, 2024
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated CholesterolYiyi Zhang, Jacqueline S Dron, Brandon K Bellows, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Cerebellum (London, England)|December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
Pageof 7